We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Trade smarter, not harder: Unleash your inner pro with our toolkit and live discussions.
The current GLMD market cap is 1.98M. The company's latest EPS is USD -10.7381 and P/E is -0.29.
| Quarter End | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Revenue | 0 | 0 | 0 | 0 | 0 |
| Operating Income | -1.47M | -2.15M | -1.4M | -1.22M | -2.01M |
| Net Income | -1.47M | -2.02M | -1.28M | -1.12M | -1.91M |
| Year End 31 December 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Revenue | 0 | 0 | 0 | 0 | 0 |
| Operating Income | -22.38M | -30.21M | -32.88M | -17.65M | -7.49M |
| Net Income | -20.46M | -28.77M | -32.47M | -17.87M | -6.91M |
| Quarter End | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Assets | 17.64M | 16.63M | 14.52M | 13.34M | 20.95M |
| Total Liabilities | 2.09M | 2.75M | 1.77M | 1.55M | 2.51M |
| Total Equity | 15.55M | 13.88M | 12.76M | 11.79M | 18.44M |
| Year End 31 December 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Assets | 77.14M | 52.38M | 36.61M | 16.56M | 16.63M |
| Total Liabilities | 7.29M | 8.23M | 6.11M | 3.14M | 2.75M |
| Total Equity | 69.85M | 44.15M | 30.5M | 13.42M | 13.88M |
| Quarter End | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Operating | -5.24M | -6.14M | -1.83M | -2.85M | -3.91M |
| Investing | -1.48M | 800k | 432k | 1.82M | 2.44M |
| Financing | 6.19M | 6.19M | N/A | N/A | 8.34M |
| Year End 31 December 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Operating | -14.94M | -26.29M | -32.89M | -18.5M | -6.14M |
| Investing | 6.68M | 16.54M | 11.46M | 17.56M | 800k |
| Financing | 143k | 768k | 17.37M | 70k | 6.19M |
| Market Cap | 1.98M |
| Price to Earnings Ratio | -0.29 |
| Price to Sales Ratio | 0 |
| Price to Cash Ratio | 0.69 |
| Price to Book Ratio | 0.14 |
| Dividend Yield | - |
| Shares Outstanding | 643.69k |
| Average Volume (1 week) | 31.93k |
| Average Volume (1 Month) | 47.25k |
| 52 Week Change | -43.15% |
| 52 Week High | 23.80 |
| 52 Week Low | 2.56 |
| Spread (Intraday) | 0.05 (1.6%) |
| Company Name | Galmed Pharmaceuticals Ltd |
| Address |
16 tiomkin street tel aviv, center 6578317 |
| Website | https://www.galmedpharma.com |
| Industry | pharmaceutical preparations (2834) |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions
Hot Features
Premium
